| [Download PDF]
|Year : 2008 | Volume
| Issue : 7 | Page : 3-
About our Guest Editor
|How to cite this article:|
. About our Guest Editor.Indian J Pharmacol 2008;40:3-3
|How to cite this URL:|
. About our Guest Editor. Indian J Pharmacol [serial online] 2008 [cited 2023 Feb 6 ];40:3-3
Available from: https://www.ijp-online.com/text.asp?2008/40/7/3/40234
Dr. Pipasha Biswas is currently Principal Consultant & Director of Symogen Ltd, UK, which is her own company which undertakes consultancy work and projects on all aspects of Pharmacovigilance & Pharmacoepidemiology. She has been involved in pharmacovigilance for the last 12 years in Europe, USA and India. She has worked in a number of MNCs in Pharmacovigilance as Executive Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety. In the UK, she worked as Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, where she was the lead physician responsible for Respiratory and Antiinflammatory therapeutic area. Prior to working at GSK, London, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK. Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance.
She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III.
She qualified in Medicine from VSS Medical College, University of Sambalpur, India and then trained in Internal Medicine and did her post graduation in Pharmaceutical Medicine, from University of Surrey, UK. She then specialized in Pharmacovigilance & Pharmacoepidemiology from London School of Hygiene and Tropical Medicine, London and then did her DM in Pharmacoepidemiology from University of Southampton, UK.
She is the Member of British Association of Regulatory and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE). She is also Affiliate Member of the Faculty of Pharmacuetical Medicine, of The Royal College of Physicians, London, UK. She has been recently conferred with the Fellowship of The Royal Society of Medicine, UK.